Kura Oncology Ownership | Who Owns Kura Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Kura Oncology Ownership Summary


Kura Oncology is owned by 56.53% institutional investors, 2.13% insiders, and 41.35% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.28% of KURA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.69% of its assets in Kura Oncology shares.

KURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKura Oncology56.53%2.13%41.35%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.01M10.28%$93.62M
Bvf inc/il8.62M9.84%$76.26M
Suvretta capital management8.12M9.27%$71.83M
Blackrock6.97M8.30%$143.43M
Vanguard group5.51M6.28%$57.22M
Armistice capital4.67M5.33%$41.35M
State street3.34M3.82%$29.59M
Prosight management, lp2.53M2.89%$26.28M
Millennium management2.37M2.72%$20.62M
Geode capital management2.03M2.31%$21.08M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management1.42M7.18%$14.78M
Prosight management, lp2.53M5.43%$26.28M
Bvf inc/il8.62M3.09%$76.26M
Lion point capital, lp46.00K2.31%$407.10K
Suvretta capital management8.12M1.84%$71.83M
1492 capital management452.64K1.80%$4.70M
Boxer capital1.00M1.08%$20.59M
Sector gamma as455.84K1.08%$4.74M
Dafna capital management463.37K1.01%$4.10M
Artal group1.82M0.96%$37.47M

Top Buyers

HolderShares% AssetsChange
Millennium management2.37M0.01%1.52M
Renaissance1.83M0.03%965.26K
Bvf inc/il8.62M3.09%863.03K
Nan fung trinity (hk)964.88K0.79%734.00K
D. e. shaw1.15M0.01%727.99K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)---5.41M
Paradigm biocapital advisors lp---4.33M
Ra capital management---4.00M
Ecor1 capital872.50K0.37%-3.33M
Avoro capital advisors---2.25M

New Positions

HolderShares% AssetsChangeValue
Fisher asset management471.99K0.00%471.99K$4.90M
Great lakes advisors390.23K0.03%390.23K$4.05M
Susquehanna portfolio strategies343.89K0.05%343.89K$3.04M
Eversept partners, lp263.63K0.16%263.63K$2.33M
Sei investments183.45K0.00%183.45K$1.91M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Wealthspire advisors-10.00
Quantbot technologies lp-14.00
Nelson, van denburg & campbell wealth management group-14.00
Smartleaf asset management-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025155-25.12%49,542,038-40.99%560.62%92-22.69%38-26.92%
Sep 30, 20251977.07%77,024,381-6.25%871.00%112-0.89%5016.28%
Jun 30, 2025183-2.14%82,143,9175.53%931.18%11216.67%43-24.56%
Mar 31, 2025187-1.06%80,458,6251.94%921.12%97-19.83%5762.86%
Dec 31, 2024104-43.48%28,722,448-65.13%330.37%68-17.07%14-75.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF3.21M3.69%-17.29K
Vanguard Total Stock Mkt Idx Inv2.73M3.13%-
Vanguard US Total Market Shares ETF2.17M2.68%3.54K
iShares Russell 2000 ETF1.95M2.24%551.27K
HBM Healthcare Investments AG Ord1.69M1.94%475.32K
SPDR® S&P Biotech ETF1.28M1.48%2.86K
Vanguard Institutional Extnd Mkt Idx Tr947.09K1.09%-6.42K
Invesco MSCI World ETF897.58K1.03%897.58K
Rhenman Healthcare Equity L/S RC2 SEK834.00K0.96%344.00K
Fidelity Small Cap Index819.96K0.94%13.47K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 27, 2026Powl Brian T. Chief Commercial OfficerSell$40.97K
Jan 27, 2026Powl Brian T. Chief Commercial OfficerSell$13.30K
Jan 27, 2026FORD KATHLEEN Chief Operating OfficerSell$15.34K
Jan 27, 2026Leoni Mollie Chief Medical OfficerSell$30.92K
Jan 27, 2026Leoni Mollie Chief Medical OfficerSell$18.89K

Insider Transactions Trends


DateBuySell
2026 Q1-16
2025 Q4-7
2025 Q336
2025 Q2-2
2025 Q1-15

KURA Ownership FAQ


Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 56.53%, followed by 2.13% insiders and 41.34% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 381.47%, which Kura Oncology falls below.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Blackrock funding, inc. /de (9.01M shares, 10.28%), Bvf inc/il (8.62M shares, 9.84%), and Suvretta capital management (8.12M shares, 9.27%). Together, they hold 29.39% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 7.18% of its assets in 1.42M Kura Oncology shares, valued at 14.78M$.

Who is the top mutual fund holder of Kura Oncology shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Kura Oncology shares, with 3.69% of its total shares outstanding invested in 3.21M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools